奥科达
New Jersey, US · 1 known investors
Find your way into 奥科达
Sign up to see every warm intro you have to 奥科达
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 奥科达 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A research-driven specialty pharmaceutical company that develops and commercializes innovative medicines through the 505(b)(2) regulatory pathway, focusing on central nervous system disorders, metabolic diseases, and orphan indications. The company operates in New Jersey and Shanghai, leveraging established molecules with proven safety profiles.
Founders & leadership
SL
Shoufeng LiChief Executive Officer
Investors · 1
Frequently asked questions
- What does 奥科达 do?
- A research-driven specialty pharmaceutical company that develops and commercializes innovative medicines through the 505(b)(2) regulatory pathway, focusing on central nervous system disorders, metabolic diseases, and orphan indications. The company operates in New Jersey and Shanghai, leveraging established molecules with proven safety profiles.
- Who founded 奥科达?
- 奥科达 was founded by Shoufeng Li.
- Who are 奥科达's investors?
- 奥科达's investors include Sangel Capital.
- Where is 奥科达 headquartered?
- 奥科达 is headquartered in New Jersey, US.